Here we go
(limited safety data)
As I remember, Tamiflu is not effective against this novel H1N1 strain. This is the first of approvals for use without adequate testing. The makers of the drug, Hoffmann-La Roche, are required to provide information to Health Canada, as it becomes available, about its safety and effectiveness. Adverse reactions must be reported to Health Canada. Parents should be informed about "exceptional use." The vaccine is not mandatory. This is relevant in Canada, USA and EU. It looks like a new test group.
Health officials OK Tamiflu for children under one
Published: Thursday, July 23, 2009
http://www.nationalpost.com/news/story.html?id=1820956
OTTAWA -- The Public Health Agency of Canada is advising doctors they can prescribe Tamiflu for children under age one despite limited safety data on its use in patients that young.
Health Minister Leona Aglukkaq signed an interim order this week authorizing the use of the drug as a prophylaxis or treatment for children under one year who have been infected with the swine flu virus, also known as H1N1.
"Although there are limited data supporting the use of Tamiflu in children under one, there now exists an urgent need for recommendations to treat this population, given this group's increased risk for morbidity and mortality from influenza," said the notice posted on PHAC's website.
The move to allow for the expanded use of Tamiflu follows the same decision by the Food and Drug Administration in the United States and the European Health Agency.
Tamiflu and Relenza are the two antiviral medications that are being used to treat Canadians with swine flu.